Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Selling, General & Administrative
Modalis Therapeutics Corp
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
Selling, General & Administrative
-¥267.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Selling, General & Administrative
-¥14.6B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-34%
|
|
PeptiDream Inc
TSE:4587
|
Selling, General & Administrative
-¥7.3B
|
CAGR 3-Years
-93%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Selling, General & Administrative
-¥15.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Selling, General & Administrative
-¥45B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-53%
|
|
S
|
StemRIM Inc
TSE:4599
|
Selling, General & Administrative
-¥608.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Selling, General & Administrative?
Selling, General & Administrative
-267.8m
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Selling, General & Administrative amounts to -267.8m JPY.
What is Modalis Therapeutics Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-34%
Over the last year, the Selling, General & Administrative growth was -11%. The average annual Selling, General & Administrative growth rates for Modalis Therapeutics Corp have been -9% over the past three years , -34% over the past five years .